{"id":"NCT02684370","sponsor":"AbbVie","briefTitle":"BI 655066 (Risankizumab) Compared to Placebo and Active Comparator (Ustekinumab) in Patients With Moderate to Severe Chronic Plaque Psoriasis","officialTitle":"BI 655066/ABBV-066 (Risankizumab) Versus Ustekinumab and Placebo Comparators in a Randomized Double Blind trIal for Maintenance Use in Moderate to Severe Plaque Type Psoriasis (UltIMMa-1)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2016-02","primaryCompletion":"2016-12","completion":"2017-09","firstPosted":"2016-02-18","resultsPosted":"2019-06-18","lastUpdate":"2021-07-30"},"enrollment":560,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Psoriasis"],"interventions":[{"type":"DRUG","name":"risankizumab","otherNames":["ABBV-066","BI 655066","SKYRIZI"]},{"type":"DRUG","name":"placebo for risankizumab","otherNames":[]},{"type":"DRUG","name":"ustekinumab","otherNames":[]},{"type":"DRUG","name":"placebo for ustekinumab","otherNames":[]}],"arms":[{"label":"Placebo (Part A)","type":"PLACEBO_COMPARATOR"},{"label":"Ustekinumab (Part A)","type":"ACTIVE_COMPARATOR"},{"label":"Risankizumab (Part A)","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to assess the safety and efficacy of BI 655066/ABBV-066 (risankizumab) for the treatment of moderate to severe chronic plaque psoriasis in adult patients.","primaryOutcome":{"measure":"Percentage of Participants Achieving 90% Improvement in Psoriasis Area and Severity Index (PASI) Score (PASI90) at Week 16 in Participants Who Received Risankizumab Compared With Placebo (Part A)","timeFrame":"Week 16","effectByArm":[{"arm":"Placebo (Part A)","deltaMin":4.9,"sd":null},{"arm":"Risankizumab (Part A)","deltaMin":75.3,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":3},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["30097359","35839335","34921669","33052382","31667790","31054118"],"seeAlso":["http://rxabbvie.com"]},"adverseEventsSummary":{"seriousAny":{"events":3,"n":102},"commonTop":["Viral upper respiratory tract infection","Upper respiratory tract infection","Headache","Urinary tract infection","Psoriasis"]}}